NCT06439758View on ClinicalTrials.gov

Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

111

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

December 1, 2025

Conditions

Diabetes Type 2Osteoporosis

Interventions

DRUG

Metformin

Metformin 1000 mg/day for 6 months

BEHAVIORAL

Lifestyle

Dietary lifestyle modifications

All Listed Sponsors

lead

King Saud University

OTHER